Bibliography
- Simons JW, Sacks N. Granulocyte-macrophage colony-stimulating factor–transduced allogeneic cancer cellular immunotherapy: the GVAX vaccine for prostate cancer. Urol Oncol 2006;24:419-24
- Wada S, Yoshimura K, Hipkiss EL, Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model. Cancer Res 2009;69:4309-18
- Ercolini AM, Ladle BH, Manning EA, Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune response. J Exp Med 2005;201:1591-602
- Machiels JP, Reilly RT, Emens LA, Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor–secreting whole-cell vaccines in HER-2/neu tolerized mice. Cancer Res 2001;61:3689-97
- Emens LA, Armstrong D, Biedrzycki B, A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF–secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin. Hum Gene Ther 2004;15:313-37
- Emens LA, Asquith JM, Leatherman JM, Increasing doses of cyclophosphamide suppress antigen-specific T helper-dependent immunity induced by a GM-CSF–secreting breast tumor vaccine. J Clin Oncol 2009;27:5911-8
- Laheru D, Lutz E, Burke J, Allogeneic granulocyte-macrophage colony-stimulating factor–secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation. Clin Cancer Res 2008;14:1455-63
- Higano C, Saad F, Somer B, A phase III trial of GVAX immunotherapy for prostate cancer versus docetaxel plus prednisone in asymptomatic, castration-resistant prostate cancer. Genitourin Cancer Symp, Orlando, FL, USA, 26-28 Feb 2009; abstract LBA150
- Small E, Demkow T, Gerritsen WR, A phase III trial of GVAX immunotherapy for prostate cancer in combination with docetaxel versus docetaxel plus prednisone in symptomatic, castration-resistant prostate cancer. Genitourin Cancer Symp, Orlando, FL, USA, 26-28 Feb 2009; abstract 7
- Drake CG, Jaffee E, Pardoll DM. Mechanisms of immune evasion by tumors. Adv Immunol 2006;90:51-81